These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 33093219)

  • 41. Precise Spatiotemporal Interruption of Regulatory T-cell-Mediated CD8
    Zhou X; Zhao S; He Y; Geng S; Shi Y; Wang B
    Cancer Res; 2019 Feb; 79(3):585-597. PubMed ID: 30254146
    [TBL] [Abstract][Full Text] [Related]  

  • 42. PI3Kγδ inhibitor plus radiation enhances the antitumour immune effect of PD-1 blockade in syngenic murine breast cancer and humanised patient-derived xenograft model.
    Han MG; Jang BS; Kang MH; Na D; Kim IA
    Eur J Cancer; 2021 Nov; 157():450-463. PubMed ID: 34601286
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increased tumor-infiltrating CD45RA
    Mao FY; Kong H; Zhao YL; Peng LS; Chen W; Zhang JY; Cheng P; Wang TT; Lv YP; Teng YS; Fu XL; Liu YG; Wu XL; Hao CJ; You N; Luo P; Yu PW; Zou QM; Guo G; Zhuang Y
    Cell Death Dis; 2017 Aug; 8(8):e3002. PubMed ID: 28817117
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Differential contribution of three immune checkpoint (VISTA, CTLA-4, PD-1) pathways to antitumor responses against squamous cell carcinoma.
    Kondo Y; Ohno T; Nishii N; Harada K; Yagita H; Azuma M
    Oral Oncol; 2016 Jun; 57():54-60. PubMed ID: 27208845
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dysregulation of Glutamate Transport Enhances Treg Function That Promotes VEGF Blockade Resistance in Glioblastoma.
    Long Y; Tao H; Karachi A; Grippin AJ; Jin L; Chang YE; Zhang W; Dyson KA; Hou AY; Na M; Deleyrolle LP; Sayour EJ; Rahman M; Mitchell DA; Lin Z; Huang J
    Cancer Res; 2020 Feb; 80(3):499-509. PubMed ID: 31723000
    [TBL] [Abstract][Full Text] [Related]  

  • 46. PD-1 blockade enhances radio-immunotherapy efficacy in murine tumor models.
    Zhuang Y; Li S; Wang H; Pi J; Xing Y; Li G
    J Cancer Res Clin Oncol; 2018 Oct; 144(10):1909-1920. PubMed ID: 30074066
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Roles of regulatory T cells in cancer immunity.
    Takeuchi Y; Nishikawa H
    Int Immunol; 2016 Aug; 28(8):401-9. PubMed ID: 27160722
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Acidity-mediated induction of FoxP3
    Rao D; Stunnenberg JA; Lacroix R; Dimitriadis P; Kaplon J; Verburg F; van van Royen PT; Hoefsmit EP; Renner K; Blank CU; Peeper DS
    Eur J Immunol; 2023 Jun; 53(6):e2250258. PubMed ID: 36788428
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intratumoral stem-like CCR4+ regulatory T cells orchestrate the immunosuppressive microenvironment in HCC associated with hepatitis B.
    Gao Y; You M; Fu J; Tian M; Zhong X; Du C; Hong Z; Zhu Z; Liu J; Markowitz GJ; Wang FS; Yang P
    J Hepatol; 2022 Jan; 76(1):148-159. PubMed ID: 34689996
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treg depletion potentiates checkpoint inhibition in claudin-low breast cancer.
    Taylor NA; Vick SC; Iglesia MD; Brickey WJ; Midkiff BR; McKinnon KP; Reisdorf S; Anders CK; Carey LA; Parker JS; Perou CM; Vincent BG; Serody JS
    J Clin Invest; 2017 Sep; 127(9):3472-3483. PubMed ID: 28825599
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Regulatory T cells and myeloid-derived suppressor cells in the tumor microenvironment undergo Fas-dependent cell death during IL-2/αCD40 therapy.
    Weiss JM; Subleski JJ; Back T; Chen X; Watkins SK; Yagita H; Sayers TJ; Murphy WJ; Wiltrout RH
    J Immunol; 2014 Jun; 192(12):5821-9. PubMed ID: 24808361
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Complement c5a receptor facilitates cancer metastasis by altering T-cell responses in the metastatic niche.
    Vadrevu SK; Chintala NK; Sharma SK; Sharma P; Cleveland C; Riediger L; Manne S; Fairlie DP; Gorczyca W; Almanza O; Karbowniczek M; Markiewski MM
    Cancer Res; 2014 Jul; 74(13):3454-65. PubMed ID: 24786787
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Specific recruitment of γδ regulatory T cells in human breast cancer.
    Ye J; Ma C; Wang F; Hsueh EC; Toth K; Huang Y; Mo W; Liu S; Han B; Varvares MA; Hoft DF; Peng G
    Cancer Res; 2013 Oct; 73(20):6137-48. PubMed ID: 23959855
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tumor-infiltrating lymphocytes, tumor characteristics, and recurrence in patients with early breast cancer.
    Kim ST; Jeong H; Woo OH; Seo JH; Kim A; Lee ES; Shin SW; Kim YH; Kim JS; Park KH
    Am J Clin Oncol; 2013 Jun; 36(3):224-31. PubMed ID: 22495453
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Solanine Inhibits Immune Escape Mediated by Hepatoma Treg Cells via the TGF
    Gao J; Ying Y; Wang J; Cui Y
    Biomed Res Int; 2020; 2020():9749631. PubMed ID: 33204731
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Depleting tumor-associated Tregs via nanoparticle-mediated hyperthermia to enhance anti-CTLA-4 immunotherapy.
    Chen H; Luan X; Paholak HJ; Burnett JP; Stevers NO; Sansanaphongpricha K; He M; Chang AE; Li Q; Sun D
    Nanomedicine (Lond); 2020 Jan; 15(1):77-92. PubMed ID: 31868112
    [No Abstract]   [Full Text] [Related]  

  • 57. Combination of Sunitinib and PD-L1 Blockade Enhances Anticancer Efficacy of TLR7/8 Agonist-Based Nanovaccine.
    Kim H; Khanna V; Kucaba TA; Zhang W; Ferguson DM; Griffith TS; Panyam J
    Mol Pharm; 2019 Mar; 16(3):1200-1210. PubMed ID: 30620878
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Direct and Indirect Effect of TGFβ on Treg Transendothelial Recruitment in HCC Tissue Microenvironment.
    Dituri F; Mancarella S; Serino G; Chaoul N; Lupo LG; Villa E; Fabregat I; Giannelli G
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769191
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tumor-derived chemokine CCL5 enhances TGF-β-mediated killing of CD8(+) T cells in colon cancer by T-regulatory cells.
    Chang LY; Lin YC; Mahalingam J; Huang CT; Chen TW; Kang CW; Peng HM; Chu YY; Chiang JM; Dutta A; Day YJ; Chen TC; Yeh CT; Lin CY
    Cancer Res; 2012 Mar; 72(5):1092-102. PubMed ID: 22282655
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tumor-derived γδ regulatory T cells suppress innate and adaptive immunity through the induction of immunosenescence.
    Ye J; Ma C; Hsueh EC; Eickhoff CS; Zhang Y; Varvares MA; Hoft DF; Peng G
    J Immunol; 2013 Mar; 190(5):2403-14. PubMed ID: 23355732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.